Effect of Two-Year Caloric Restriction on Bone Metabolism and Bone Mineral Density in Non-Obese Younger Adults: A Randomized Clinical Trial

Journal of Bone and Mineral Research

Volumn 31, Issue 1, 2016, Pages 40-51

  Villareal, Dennis T ^a,b   Fontana, Luigi ^a,c,d   Das, Sai Krupa ^e   Redman, Leanne ^f   Smith, Steven R ^f,g   Saltzman, Edward ^e   Bales, Connie ^h,i   Rochon, James ^i,j   Pieper, Carl ⁱ   Huang, Megan ⁱ   Lewis, Michael ^k   Schwartz, Ann V ^l  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Medicina del Lavoro e Igiene Industrial   (Italy)

^d CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^e TUFTS UNIVERSITY   (United States)

^f PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^g FLORIDA HOSPITAL   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^j Rho Federal Systems   (United States)

^k UNIVERSITY OF VERMONT   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

BONE FAT INTERACTIONS; BONE MUSCLE INTERACTIONS; DXA; FRACTURE PREVENTION; NUTRITION

Indexed keywords

25 HYDROXYVITAMIN D; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ADIPONECTIN; ALKALINE PHOSPHATASE; BONE SPECIFIC ALKALINE PHOSPHATASE; CARBOXY TERMINAL TELOPEPTIDE; HYDROCORTISONE; INSULIN; LEPTIN; PARATHYROID HORMONE; SOMATOMEDIN C; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; ARTICLE; BODY COMPOSITION; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CALORIC RESTRICTION; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FAT FREE MASS; FAT MASS; FEMALE; FEMUR NECK; HIP; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; LUMBAR SPINE; MALE; NORMAL HUMAN; NUTRIENT UPTAKE; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; WEIGHT REDUCTION; ADVERSE EFFECTS; AGING; BLOOD; BODY WEIGHT; CLINICAL TRIAL; COMPARATIVE STUDY; LUMBAR VERTEBRA; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; OSTEOPOROSIS;

ADULT; AGING; BIOMARKERS; BODY WEIGHT; BONE DENSITY; CALORIC RESTRICTION; FEMALE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS;

EID: 84957442302     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2701     Document Type: Article

References (54)

1. Fontana L, Partridge L, Longo VD., Extending healthy life span-from yeast to humans. Science. 2010; 328: 321-6.
2. Racette SB, Weiss EP, Villareal DT, et al., One year of caloric restriction in humans: feasibility and effects on body composition and abdominal adipose tissue. J Gerontol A Biol Sci Med Sci. 2006; 61: 943-50.
3. Heilbronn LK, de Jonge L, Frisard MI, et al., Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA. 2006; 295: 1539-48.
4. Larson-Meyer DE, Heilbronn LK, Redman LM, et al., Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care. 2006; 29: 1337-44.
5. Weiss EP, Racette SB, Villareal DT, et al., Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am J Clin Nutr. 2006; 84: 1033-42.
6. Schwartz AV, Johnson KC, Kahn SE, et al., Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: results from the Look AHEAD randomized trial. J Bone Miner Res. 2012; 27: 619-27.
7. Villareal DT, Shah K, Banks MR, Sinacore DR, Klein S., Effect of weight loss and exercise therapy on bone metabolism and mass in obese older adults: a one-year randomized controlled trial. J Clin Endocrinol Metab. 2008; 93: 2181-7.
8. Riedt CS, Cifuentes M, Stahl T, Chowdhury HA, Schlussel Y, Shapses SA., Overweight postmenopausal women lose bone with moderate weight reduction and 1 g/day calcium intake. J Bone Miner Res. 2005; 20: 455-63.
9. Jensen LB, Kollerup G, Quaade F, Sorensen OH., Bone minerals changes in obese women during a moderate weight loss with and without calcium supplementation. J Bone Miner Res. 2001; 16: 141-7.
10. Ricci TA, Heymsfield SB, Pierson RN Jr, Stahl T, Chowdhury HA, Shapses SA., Moderate energy restriction increases bone resorption in obese postmenopausal women. Am J Clin Nutr. 2001; 73: 347-52.
11. Avenell A, Richmond PR, Lean ME, Reid DM., Bone loss associated with a high fibre weight reduction diet in postmenopausal women. Eur J Clin Nutr. 1994; 48: 561-6.
12. Svendsen OL, Hassager C, Christiansen C., Effect of an energy-restrictive diet, with or without exercise, on lean tissue mass, resting metabolic rate, cardiovascular risk factors, and bone in overweight postmenopausal women. Am J Med. 1993; 95: 131-40.
13. Riedt CS, Schlussel Y, von Thun N et al. Premenopausal overweight women do not lose bone during moderate weight loss with adequate or higher calcium intake. Am J Clin Nutr. 2007; 85: 972-80.
14. Redman LM, Rood J, Anton SD, Champagne C, Smith SR, Ravussin E., Calorie restriction and bone health in young, overweight individuals. Arch Intern Med. 2008; 168: 1859-66.
15. Shapses SA, von Thun NL, Heymsfield SB, et al., Bone turnover and density in obese premenopausal women during moderate weight loss and calcium supplementation. J Bone Miner Res. 2001; 16: 1329-36.
16. Uusi-Rasi K, Rauhio A, Kannus P, et al., Three-month weight reduction does not compromise bone strength in obese premenopausal women. Bone. 2010; 46: 1286-93.
17. Villareal DT, Fontana L, Weiss EP, et al., Bone mineral density response to caloric restriction-induced weight loss or exercise-induced weight loss: a randomized controlled trial. Arch Intern Med. 2006; 166: 2502-10.
18. Ravussin, Redman LM, Rochon J, et al., A two-year randomized controlled trial of human caloric restrcition: feasibility and effects on predictors of health span and longevity. J Gerontol A Biol Sci Med Sci. 2015; 70: 1097-104.
19. Rochon J, Bales CW, Ravussin E, et al., Design and conduct of the CALERIE study: comprehensive assessment of the long-term effects of reducing intake of energy. J Gerontol A Biol Sci Med Sci. 2011; 66: 97-108.
20. Rickman AD, Williamson DA, Martin CK, et al., The CALERIE study: design and methods of an innovative 25% caloric restriction intervention. Contemp Clin Trials. 2011; 32: 874-81.
21. Stewart TM, Bhapkar M, Das S, et al., Comprehensive assessment of long-term effects of reducing intake of energy phase 2 (CALERIE phase 2) screening and recruitment: methods and results. Contemp Clin Trials. 2013; 34: 10-20.
22. Redman LM, Kraus WE, Bhapkar M, et al., Energy requirements in nonobese men and women: results from CALERIE. Am J Clin Nutr. 2014; 99: 71-8.
23. Pieper C, Redman L, Racette S, et al., Development of adherence metrics for caloric restriction interventions. Clin Trials. 2011; 8: 155-64.
24. Blair SN, Haskell WL, Ho P, et al. Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol. 1985; 122: 794-804.
25. Diggle PJ, Heagerty P, Liang K-Y., Zeger SL., Analysis of longitudinal data. 2nd ed. New York: Oxford University Press 2002.
26. Jennrich RI, Schluchter MD., Unbalanced repeated-measures models with structured covariance matrices. Biometrics. 1986; 42: 805-20.
27. Dmitrienko A, Millen BA, Brechenmacher T, Paux G., Development of gatekeeping strategies in confirmatory clinical trials. Biom J. 2011;53:875-93.
28. Wright S., Adjusted p-values for simultaneous inference. Biometrics. 1992; 48: 1005-13.
29. Fontana L, Villareal DT, Das SK, et al., Effect of 2-year caloric restriction on circulating levels of IGF-1, IGF-binding proteins, and cortisol in non-obese men and women: a randomized clinical trial. Aging Cell. In press.
30. Reid IR., Relationships among body mass, its components, and bone. Bone. 2002; 31: 547-55.
31. Bonnick SL., Skeletal anatomy in densitometry. In: Bonnick SL, editor. Bone densitometry in clinical practice: application and interpretation. New York: Humana Press 2010. pp 35-78.
32. Rachner TD, Khosla S, Hofbauer LC., Osteoporosis: now and the future. Lancet. 2011; 377: 1276-87.
33. Crockett JC, Rogers MJ, Coxon FP, Hocking LJ, Helfrich MH., Bone remodelling at a glance. J Cell Sci. 2011; 124: 991-8.
34. Shah K, Armamento-Villareal R, Parimi N, et al., Exercise training in obese older adults prevents increase in bone turnover and attenuates decrease in hip bone mineral density induced by weight loss despite decline in bone-active hormones. J Bone Miner Res. 2011; 26: 2851-9.
35. Reid IR, Cornish J, Baldock PA., Nutrition-related peptides and bone homeostasis. J Bone Miner Res. 2006; 21: 495-500.
36. Shapses SA, Sukumar D., Bone metabolism in obesity and weight loss. Annu Rev Nutr. 2012; 32: 287-309.
37. Masoro EJ., The role of hormesis in life extension by dietary restriction. Interdiscip Top Gerontol. 2007; 35:1-17.
38. Mason C, Xiao L, Imayama I, et al., Effects of weight loss on serum vitamin D in postmenopausal women. Am J Clin Nutr. 2011; 94: 95-103.
39. Semenov M, Tamai K, He X. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem. 2005; 280: 26770-5.
40. Sutherland MK, Geoghegan JC, Yu C, et al. Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation. Bone. 2004; 35: 828-35.
41. Armamento-Villareal R, Sadler C, Napoli N, et al., Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training. J Bone Miner Res. 2012; 27: 1215-21.
42. Weinheimer EM, Sands LP, Campbell WW., A systematic review of the separate and combined effects of energy restriction and exercise on fat-free mass in middle-aged and older adults: implications for sarcopenic obesity. Nutr Rev. 2010; 68: 375-88.
43. Armamento-Villareal R, Aguirre L, Napoli N, et al., Changes in thigh muscle volume predict bone mineral density response to lifestyle therapy in frail, obese older adults. Osteoporos Int. 2014; 25: 551-8.
44. Bonewald LF, Kiel DP, Clemens TL, et al., Forum on bone and skeletal muscle interactions: summary of the proceedings of an ASBMR workshop. J Bone Miner Res. 2013; 28: 1857-65.
45. Looker AC, Borrud LG, Hughes JP, et al., Lumbar spine and proximal femur bone mineral density, bone mineral content, and bone area: United States, 2005-2008. National Center for Health Statistics. Vital Health Stat. 2012;11(251).
46. Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E., FRAX and its applications to clinical practice. Bone. 2009; 44: 734-43.
47. Wing RR, Bolin P, Brancati FL, et al., Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013; 369: 145-54.
48. Waters DL, Vawter R, Qualls C, Chode S, Armamento-Villareal R, Villareal DT., Long-term maintenance of weight loss after lifestyle intervention in frail, obese older adults. J Nutr Health Aging. 2013; 17: 3-7.
49. Villalon KL, Gozansky WS, Van Pelt RE, et al., A losing battle: weight regain does not restore weight loss-induced bone loss in postmenopausal women. Obesity (Silver Spring). 2011; 19: 2345-50.
50. Seeman E, Delmas PD., Bone quality-the material and structural basis of bone strength and fragility. N Engl J Med. 2006; 354: 2250-61.
51. Villareal DT, Kotyk JJ, Armamento-Villareal RC, et al., Reduced bone mineral density is not associated with significantly reduced bone quality in men and women practicing long-term calorie restriction with adequate nutrition. Aging Cell. 2011; 10: 96-102.
52. Tothill P, Hannan WJ., Comparisons between Hologic QDR 1000W, QDR 4500A, and Lunar Expert dual-energy X-ray absorptiometry scanners used for measuring total body bone and soft tissue. Ann NY Acad Sci. 2000; 904: 63-71.
53. Civitelli R, Armamento-Villareal R, Napoli N., Bone turnover markers: understanding their value in clinical trials and clinical practice. Osteoporos Int. 2009; 20: 843-51.
54. Holloszy JO,. Mortality rate and longevity of food-restricted exercising male rats: a reevaluation. J Appl Physiol (1985). 1997; 82: 399-403.